Showing 26–50 of 67 international scientific journals (Oncology)
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | Therapeutic Advances in Medical Oncology ISSN: 1758-8340 / 1758-8359 | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 4.1 | 1.416Q1 | 34 | 155 | 2.3% | SAGE Publications Inc. | Profile |
| 27 | Current Hematologic Malignancy Reports ISSN: 1558-8211 / 1558-822XTop Tier | 🇺🇸United States | Q2 | CAS Tier 3 | 4 | 1.191Q1 | 28 | 55 | 3.7% | Springer US | Profile |
| 28 | Oncology Reviews ISSN: 1970-5557 / 1970-5565Top Tier | 🌐Italy | Q2 | CAS Tier 3 | 4 | 1.096Q2 | — | 14 | 0% | PAGEPress Publications | Profile |
| 29 | Clinical Lung Cancer ISSN: 1525-7304 / 1938-0690 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.9 | 1.362Q1 | 52 | 182 | 3% | Elsevier | Profile |
| 30 | Journal of Hepatocellular Carcinoma ISSN: 2253-5969 | 🌐New Zealand | Q2 | CAS Tier 3 | 3.9 | 0.809Q2 | — | 119 | 7.1% | DOVE MEDICAL PRESS LTD | Profile |
| 31 | BJC Reports ISSN: 2731-9377 | 🌐International | Q2 | — | 3.8 | — | — | — | N/A | SPRINGERNATURE | Profile |
| 32 | Carcinogenesis ISSN: 0143-3334 / 1460-2180 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.8 | 1.02Q1 | 189 | 152 | 0% | Oxford University Press | Profile |
| 33 | JCO Global Oncology ISSN: 2687-8941 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.8 | 1.102Q2 | — | 121 | 3.1% | American Society of Clinical Oncology | Profile |
| 34 | Breast Cancer ISSN: 1340-6868 / 1880-4233 | 🇯🇵Japan | Q1 | CAS Tier 3 | 3.7 | 1.036Q1 | 47 | 106 | 2.5% | Springer Japan | Profile |
| 35 | Clinical & Experimental Metastasis ISSN: 0262-0898 / 1573-7276 | 🇳🇱Netherlands | Q2 | CAS Tier 3 | 3.7 | 1.187Q1 | 92 | 67 | 2.4% | Springer Netherlands | Profile |
| 36 | Breast Cancer-Targets and Therapy ISSN: 1179-1314 | 🇬🇧United Kingdom | Q2 | CAS Tier 4 | 3.6 | 0.992Q2 | — | 54 | 3% | Dove Medical Press | Profile |
| 37 | Current Oncology ISSN: 1198-0052 / 1718-7729 | 🌐Canada | Q2 | CAS Tier 3 | 3.6 | 1.132Q2 | 42 | 437 | 7.1% | Multimed Inc. | Profile |
| 38 | JCO Clinical Cancer Informatics ISSN: 2473-4276 | 🌐International | Q2 | CAS Tier 3 | 3.6 | 1.174Q1 | — | 75 | 15.2% | American Society of Clinical Oncology | Profile |
| 39 | Journal of Bone Oncology ISSN: 2212-1366 | 🌐International | Q2 | CAS Tier 3 | 3.6 | — | 15 | 62 | 3.2% | Updating | Profile |
| 40 | Journal of Bone Oncology ISSN: 2212-1374 | 🇩🇪Germany | Q2 | CAS Tier 3 | 3.6 | 1.087Q2 | — | 75 | 3.2% | Elsevier GmbH | Profile |
| 41 | Journal of Breast Cancer ISSN: 1738-6756 | 🌐South Korea | Q2 | CAS Tier 4 | 3.6 | 0.89Q2 | 29 | 52 | 4.5% | Korean Breast Cancer Society | Profile |
| 42 | JTO Clinical and Research Reports ISSN: 2666-3643 | 🇺🇸United States | Q2 | CAS Tier 2 | 3.6 | 1.708Q1 | — | 108 | 3.3% | Elsevier | Profile |
| 43 | Precision Radiation Oncology ISSN: 2398-7324 | 🌐Australia | Q1 | CAS Tier 4 | 3.6 | 0.746Q2 | — | 41 | N/A | Wiley | Profile |
| 44 | Radiation Oncology ISSN: 1748-717X | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 3.6 | 1.05Q1 | 58 | 236 | 6.1% | BioMed Central | Profile |
| 45 | World Journal of Clinical Oncology ISSN: 2218-4333 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.6 | — | — | 89 | 0% | Baishideng Publishing Group | Profile |
| 46 | Cancer Medicine ISSN: 2045-7634 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.5 | 1.156Q1 | 34 | 772 | 3.4% | John Wiley and Sons Ltd | Profile |
| 47 | Cancer Treatment and Research Communications ISSN: 2468-2942 | 🇬🇧United Kingdom | Q2 | CAS Tier 4 | 3.5 | 0.995Q2 | — | 320 | N/A | Elsevier | Profile |
| 48 | Cancer Prevention Research ISSN: 1940-6207 / 1940-6215 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.4 | 1.129Q1 | 80 | 102 | 3.4% | American Association for Cancer Research Inc. | Profile |
| 49 | Journal of Cancer ISSN: 1837-9664 | 🌐Australia | Q2 | CAS Tier 3 | 3.4 | 0.852Q2 | 42 | 710 | 0% | Ivyspring International Publisher | Profile |
| 50 | Journal of Cancer Survivorship ISSN: 1932-2259 / 1932-2267 | 🇺🇸United States | Q2 | CAS Tier 2 | 3.4 | 1.151Q1 | 53 | 155 | 6.5% | Springer US | Profile |